Professor Giordano is the President and Founder of the Sbarro Health Research Organization (S.H.R.O.), which conducts research to diagnose, treat and cure cancer, cardiovascular disease, diabetes and other chronic illnesses. He is Professor of Biology at Temple University in Philadelphia and 'chiara fama’ Professor of Anatomic Pathology in the Department of Medical Biotechnology at the University of Siena, in Siena, Italy. Prof. Giordano discovered key regulators of the cell cycle and its pioneering studies contributed to the understanding of some of the central mechanisms of cancer development. He discovered, in 1993, the tumor suppressor gene RBL2/p130, whose expression is altered in a wide variety of human cancers. He identified also CDK9 and CDK10, two other key players in cell cycle regulation and cell differentiation and made important contributions to the study of the cyclin-dependent kinase inhibitor p27, which is an important prognostic factor in cancer patients. He is the author of over 600 peer-reviewed publications and book chapters, serves as a member of editorial boards of several professional journals, and frequent grant reviewer for federal and international funding agencies. Dr. Giordano has mentored over 200 hundred graduate students and post-doctoral fellows, including international researchers. In addition, Dr. Giordano is the Director of the Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology at Temple's College of Science & Technology.